PALI - Palisade Bio stock rallies 50% premarket on colitis drug update
2024-05-01 09:13:26 ET
More on Palisade Bio
- Palisade Bio stock rallies nearly 100% on colitis drug analysis
- Palisade Bio stock slides 8% amid colitis drug presentation
- Seeking Alpha’s Quant Rating on Palisade Bio
- Historical earnings data for Palisade Bio
- Financial information for Palisade Bio